HIV-1-tat protein inhibits sc35-mediated tau exon 10 inclusion through up-regulation of DYRK1A kinase

Journal of Biological Chemistry

Volumn 290, Issue 52, 2015, Pages 30931-30946

  Kadri, Ferdous ^a   Pacifici, Marco ^a   Wilk, Anna ^a   Parker Struckhoff, Amanda ^a   Del Valle, Luis ^a   Hauser, Kurt F ^b   Knapp, Pamela E ^b   Parsons, Christopher ^a   Jeansonne, Duane ^a   Lassak, Adam ^a   Peruzzi, Francesca ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BINS; CELL CULTURE; PROTEINS; RNA;

ALTERNATIVE SPLICING; CLINICAL SAMPLES; NEURONAL CELL CULTURE; NEURONAL TOXICITY; NUCLEAR SPECKLES; SPLICING FACTORS; TRANSACTIVATORS; VIRAL INFECTIONS;

NEURONS;

DYRK1A KINASE; MESSENGER RNA PRECURSOR; PROTEIN; PROTEIN KINASE; SC35 PROTEIN; TAU PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; DYRK KINASE; MAPT PROTEIN, HUMAN; MAPT PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RIBONUCLEOPROTEIN; SERINE ARGININE RICH SPLICING FACTOR; SFRS2 PROTEIN, MOUSE; SRSF2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYRK1A GENE; ENZYME INDUCTION; EXON; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA METABOLISM; RNA SPLICING; TAU GENE; VIRUS ENCEPHALITIS; VIRUS INHIBITION; ANIMAL; BIOSYNTHESIS; BRAIN; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NERVE CELL; PATHOLOGY; UPREGULATION; VIROLOGY;

ANIMALS; BRAIN; EXONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; MICE; NEURONS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RIBONUCLEOPROTEINS; SERINE-ARGININE SPLICING FACTORS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TAU PROTEINS; UP-REGULATION;

EID: 84951739232     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.675751     Document Type: Article

References (82)

1. Heaton, R. K., Clifford, D. B., Franklin, D. R., Jr., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., et al. (2010) HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75, 2087-2096
2. McArthur, J. C., Steiner, J., Sacktor, N., and Nath, A. (2010) Human immunodeficiency virus-Associated neurocognitive disorders: mind the gap. Ann. Neurol. 67, 699-714
3. Bachani, M., Sacktor, N., McArthur, J. C., Nath, A., and Rumbaugh, J. (2013) Detection of anti-tat antibodies in CSF of individuals with HIVassociated neurocognitive disorders. J. Neurovirol. 19, 82-88
4. Johnson, T. P., Patel, K., Johnson, K. R., Maric, D., Calabresi, P. A., Hasbun, R., and Nath, A. (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc. Natl. Acad. Sci. U.S.A. 110, 13588-13593
5. Panda, D., Samuel, J. C., Massie, M., Feinstein, S. C., and Wilson, L. (2003) Differential regulation of microtubule dynamics by three-And four-repeat tau: implications for the onset of neurodegenerative disease. Proc. Natl. Acad. Sci. U.S.A. 100, 9548-9553
6. Avila, J., Lucas, J. J., Perez, M., and Hernandez, F. (2004) Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84, 361-384
7. Bueé, L., Bussiére, T., Bueé-Scherrer, V., Delacourte, A., and Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130
8. Hernández, F., Pérez, M., Lucas, J. J., Mata, A. M., Bhat, R., and Avila, J. (2004) Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J. Biol. Chem. 279, 3801-3806
9. Liu, F., and Gong, C. X. (2008) Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener. 3, 8
10. Yin, X., Jin, N., Gu, J., Shi, J., Zhou, J., Gong, C. X., Iqbal, K., Grundke-Iqbal, I., and Liu, F. (2012) Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion. J. Biol. Chem. 287, 30497-30506
11. Espinoza, M., de Silva, R., Dickson, D. W., and Davies, P. (2008) Differential incorporation of tau isoforms in Alzheimer's disease. J. Alzheimers Dis. 14, 1-16
12. Shi, J., Qian, W., Yin, X., Iqbal, K., Grundke-Iqbal, I., Gu, X., Ding, F., Gong, C. X., and Liu, F. (2011) Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J. Biol. Chem. 286, 14639-14648
13. Dawson, H. N., Cantillana, V., Chen, L., and Vitek, M. P. (2007) The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. J. Neurosci. 27, 9155-9168
14. Wegiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K. C., Wegiel, J., Yang, S. M., Frackowiak, J., Mazur-Kolecka, B., Silverman, W. P., Reisberg, B., Monteiro, I., de Leon, M., Wisniewski, T., et al. (2011) Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. J. Neuropathol. Exp. Neurol. 70, 36-50
15. Foster, N. L., Wilhelmsen, K., Sima, A. A., Jones, M. Z., D'Amato, C. J., and Gilman, S. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference participants. Ann. Neurol. 41, 706-715
16. Bourgeois, C. F., Lejeune, F., and Stévenin, J. (2004) Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of premessenger RNA. Prog. Nucleic Acid Res. Mol. Biol. 78, 37-88
17. Huang, Y., Yario, T. A., and Steitz, J. A. (2004) A molecular link between SR protein dephosphorylation and mRNA export. Proc. Natl. Acad. Sci. U.S.A. 101, 9666-9670
18. Ma, X., and He, F. (2003) Advances in the study of SR protein family. Genomics Proteomics Bioinformatics 1, 2-8
19. Qian, W., Iqbal, K., Grundke-Iqbal, I., Gong, C. X., and Liu, F. (2011) Splicing factor SC35 promotes tau expression through stabilization of its mRNA. FEBS Lett. 585, 875-880
20. Qian, W., Liang, H., Shi, J., Jin, N., Grundke-Iqbal, I., Iqbal, K., Gong, C. X., and Liu, F. (2011) Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res. 39, 6161-6171
21. Ghosh, G., and Adams, J. A. (2011) Phosphorylation mechanism and structure of serine-Arginine protein kinases. FEBS J. 278, 587-597
22. Lamond, A. I., and Spector, D. L. (2003) Nuclear speckles: a model for nuclear organelles. Nat. Rev. Mol. Cell Biol. 4, 605-612
23. Spector, D. L., and Lamond, A. I. (2011) Nuclear speckles. Cold Spring Harb. Perspect. Biol. 3, a000646
24. Zhou, Z., and Fu, X. D. (2013) Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191-207
25. Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., and Díaz-Nido, J. (1999) Lithium protects cultured neurons against β-Amyloid-induced neurodegeneration. FEBS Lett. 453, 260-264
26. Dewhurst, S., Maggirwar, S. B., Schifitto, G., Gendelman, H. E., and Gelbard, H. A. (2007) Glycogen synthase kinase 3 β (GSK-3 β) as a therapeutic target in neuroAIDS. J. Neuroimmune Pharmacol. 2, 93-96
27. Eldar-Finkelman, H., and Martinez, A. (2011) GSK-3 Inhibitors: preclinical and clinical focus on CNS. Front. Mol. Neurosci. 4, 32
28. Lovestone, S., Davis, D. R., Webster, M. T., Kaech, S., Brion, J. P., Matus, A., and Anderton, B. H. (1999) Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biol. Psychiatry 45, 995-1003
29. Medina, M., and Wandosell, F. (2011) Deconstructing GSK-3: the fine regulation of its activity. Int. J. Alzheimers Dis. 2011, 479249
30. Plattner, F., Angelo, M., and Giese, K. P. (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 281, 25457-25465
31. Hämmerle, B., Ulin, E., Guimera, J., Becker, W., Guillemot, F., and Tejedor, F. J. (2011) Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development 138, 2543-2554
32. Wegiel, J., Gong, C. X., and Hwang, Y. W. (2011) The role of DYRK1A in neurodegenerative diseases. FEBS J. 278, 236-245
33. Ahn, K. J., Jeong, H. K., Choi, H. S., Ryoo, S. R., Kim, Y. J., Goo, J. S., Choi, S. Y., Han, J. S., Ha, I., and Song, W. J. (2006) DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol. Dis. 22, 463-472
34. Altafaj, X., Martín, E. D., Ortiz-Abalia, J., Valderrama, A., Lao-Peregrín, C., Dierssen, M., and Fillat, C. (2013) Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Neurobiol. Dis. 52, 117-127
35. Chen, C. K., Bregere, C., Paluch, J., Lu, J. F., Dickman, D. K., and Chang, K. T. (2014) Activity-dependent facilitation of synaptojanin and synaptic vesicle recycling by the minibrain kinase. Nat. Commun. 5, 4246
36. Grau, C., Arató, K., Fernández-Fernández, J. M., Valderrama, A., Sindreu, C., Fillat, C., Ferrer, I., de la Luna, S., and Altafaj, X. (2014) DYRK1Amediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors. Front. Cell. Neurosci. 8, 331
37. Peineau, S., Nicolas, C. S., Bortolotto, Z. A., Bhat, R. V., Ryves, W. J., Harwood, A. J., Dournaud, P., Fitzjohn, S. M., and Collingridge, G. L. (2009) A systematic investigation of the protein kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK-3 but not other serine/threonine kinases. Mol. Brain 2, 22
38. Souchet, B., Guedj, F., Sahún, I., Duchon, A., Daubigney, F., Badel, A., Yanagawa, Y., Barallobre, M. J., Dierssen, M., Yu, E., Herault, Y., Arbones, M., Janel, N., Creaú, N., and Delabar, J. M. (2014) Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. Neurobiol. Dis. 69, 65-75
39. Aprea, S., Del Valle, L., Mameli, G., Sawaya, B. E., Khalili, K., and Peruzzi, F. (2006) Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-Associated protein 2 and neuronal damage. J. Neurosci. 26, 4054-4062
40. Pacifici, M., and Peruzzi, F. (2012) Isolation and culture of rat embryonic neural cells: a quick protocol. J. Vis. Exp. 63, e3965
41. Bruce-Keller, A. J., Turchan-Cholewo, J., Smart, E. J., Geurin, T., Chauhan, A., Reid, R., Xu, R., Nath, A., Knapp, P. E., and Hauser, K. F. (2008) Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia 56, 1414-1427
42. Fitting, S., Scoggins, K. L., Xu, R., Dever, S. M., Knapp, P. E., Dewey, W. L., and Hauser, K. F. (2012) Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. Eur. J. Pharmacol. 689, 96-103
43. Passiatore, G., Rom, S., Eletto, D., and Peruzzi, F. (2009) HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity. Biochim. Biophys. Acta 1793, 378-387
44. Jeansonne, D., DeLuca, M., Marrero, L., Lassak, A., Pacifici, M., Wyc-zechowska, D., Wilk, A., Reiss, K., and Peruzzi, F. (2015) Anti-tumoral Effects of miR-3189-3p in Glioblastoma. J. Biol. Chem. 290, 8067-8080
45. Rom, S., Rom, I., Passiatore, G., Pacifici, M., Radhakrishnan, S., Del Valle, L., Piña-Oviedo, S., Khalili, K., Eletto, D., and Peruzzi, F. (2010) CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 24, 2292-2300
46. Rom, S., Pacifici, M., Passiatore, G., Aprea, S., Waligorska, A., Del Valle, L., and Peruzzi, F. (2011) HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction. Biochim. Biophys. Acta 1813, 1836-1844
47. Spector, D. L., Fu, X. D., and Maniatis, T. (1991) Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J. 10, 3467-3481
48. Fitting, S., Ignatowska-Jankowska, B. M., Bull, C., Skoff, R. P., Lichtman, A. H., Wise, L. E., Fox, M. A., Su, J., Medina, A. E., Krahe, T. E., Knapp, P. E., Guido, W., and Hauser, K. F. (2013) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biol. Psychiatry 73, 443-453
49. Fitting, S., Xu, R., Bull, C., Buch, S. K., El-Hage, N., Nath, A., Knapp, P. E., and Hauser, K. F. (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am. J. Pathol. 177, 1397-1410
50. Chen, Q., Zhou, Z., Zhang, L., Xu, S., Chen, C., and Yu, Z. (2014) The cellular distribution and Ser262 phosphorylation of tau protein are regulated by BDNF in vitro. PLoS One 9, e91793
51. Jämsä, A., Hasslund, K., Cowburn, R. F., Bäckström, A., and Vasänge, M. (2004) The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem. Biophys. Res. Commun. 319, 993-1000
52. Yu, Q., Guo, J., and Zhou, J. (2004) A minimal length between tau exon 10 and 11 is required for correct splicing of exon J. Neurochem. 90, 164-172
53. Lin, S., Coutinho-Mansfield, G., Wang, D., Pandit, S., and Fu, X. D. (2008) The splicing factor SC35 has an active role in transcriptional elongation. Nat. Struct. Mol. Biol. 15, 819-826
54. Ji, X., Zhou, Y., Pandit, S., Huang, J., Li, H., Lin, C. Y., Xiao, R., Burge, C. B., and Fu, X. D. (2013) SR proteins collaborate with 7SK and promoterassociated nascent RNA to release paused polymerase. Cell 153, 855-868
55. Bouwman, R. D., Palser, A., Parry, C. M., Coulter, E., Rasaiyaah, J., Kellam, P., and Jenner, R. G. (2014) Human immunodeficiency virus Tat associates with a specific set of cellular RNAs. Retrovirology 11, 53
56. Misteli, T., Cáceres, J. F., Clement, J. Q., Krainer, A. R., Wilkinson, M. F., and Spector, D. L. (1998) Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol. 143, 297-307
57. Aranda, S., Laguna, A., and de la Luna, S. (2011) DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J. 25, 449-462
58. Brigati, C., Giacca, M., Noonan, D. M., and Albini, A. (2003) HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol. Lett. 220, 57-65
59. Johnson, T. P., and Nath, A. (2014) New insights into immune reconstitution inflammatory syndrome of the central nervous system. Curr. Opin. HIV AIDS 9, 572-578
60. Johri, M. K., Mishra, R., Chhatbar, C., Unni, S. K., and Singh, S. K. (2011) Tits and bits of HIV Tat protein. Expert Opin. Biol. Ther. 11, 269-283
61. King, J. E., Eugenin, E. A., Buckner, C. M., and Berman, J. W. (2006) HIV tat and neurotoxicity. Microbes Infect. 8, 1347-1357
62. Peruzzi, F. (2006) The multiple functions of HIV-1 Tat: proliferation versus apoptosis. Front. Biosci. 11, 708-717
63. Del Valle, L., Croul, S., Morgello, S., Amini, S., Rappaport, J., and Khalili, K. (2000) Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 6, 221-228
64. Jablonski, J. A., Amelio, A. L., Giacca, M., and Caputi, M. (2010) The transcriptional transactivator Tat selectively regulates viral splicing. Nucleic Acids Res. 38, 1249-1260
65. Lin, S., Xiao, R., Sun, P., Xu, X., and Fu, X. D. (2005) Dephosphorylationdependent sorting of SR splicing factors during mRNP maturation. Mol. Cell 20, 413-425
66. Janke, C., Beck, M., Stahl, T., Holzer, M., Brauer, K., Bigl, V., and Arendt, T. (1999) Phylogenetic diversity of the expression of the microtubule-Associated protein tau: implications for neurodegenerative disorders. Brain Res. Mol. Brain Res. 68, 119-128
67. Kampers, T., Pangalos, M., Geerts, H., Wiech, H., and Mandelkow, E. (1999) Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett. 451, 39-44
68. Takuma, H., Arawaka, S., and Mori, H. (2003) Isoforms changes of tau protein during development in various species. Brain Res. Dev. Brain Res. 142, 121-127
69. McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., and D'Souza, I. (2008) Tau isoform regulation is region-And cell-specific in mouse brain. J. Comp. Neurol. 511, 788-803
70. Dowling, D., Nasr-Esfahani, S., Tan, C. H., O'Brien, K., Howard, J. L., Jans, D. A., Purcell, D. F., Stoltzfus, C. M., and Sonza, S. (2008) HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages. Retrovirology 5, 18
71. Maldarelli, F., Xiang, C., Chamoun, G., and Zeichner, S. L. (1998) The expression of the essential nuclear splicing factor SC35 is altered by human immunodeficiency virus infection. Virus Res. 53, 39-51
72. Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H., and Jones, K. A. (1998) A novel CDK9-Associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-Affinity, loop-specific binding to TAR RNA. Cell 92, 451-462
73. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., and Price, D. H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11, 2622-2632
74. Karn, J., and Stoltzfus, C. M. (2012) Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb. Perspect. Med. 2, a006916
75. Paz, S., Krainer, A. R., and Caputi, M. (2014) HIV-1 transcription is regulated by splicing factor SRSF1. Nucleic Acids Res. 42, 13812-13823
76. Kar, A., Fushimi, K., Zhou, X., Ray, P., Shi, C., Chen, X., Liu, Z., Chen, S., and Wu, J. Y. (2011) RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol. Cell. Biol. 31, 1812-1821
77. Korenberg, J. R., Chen, X. N., Schipper, R., Sun, Z., Gonsky, R., Gerwehr, S., Carpenter, N., Daumer, C., Dignan, P., and Disteche, C. (1994) Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. U.S.A. 91, 4997-5001
78. Dowjat, W. K., Adayev, T., Kuchna, I., Nowicki, K., Palminiello, S., Hwang, Y. W., and Wegiel, J. (2007) Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci. Lett. 413, 77-81
79. Ferrer, I., Barrachina, M., Puig, B., Martínez de Lagrán, M., Martí, E., Avila, J., and Dierssen, M. (2005) Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol. Dis. 20, 392-400
80. Lu, M., Zheng, L., Han, B., Wang, L., Wang, P., Liu, H., and Sun, X. (2011) REST regulates DYRK1A transcription in a negative feedback loop. J. Biol. Chem. 286, 10755-10763
81. Apcher, G. S., Heink, S., Zantopf, D., Kloetzel, P. M., Schmid, H. P., Mayer, R. J., and Krüger, E. (2003) Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal α and β subunits. FEBS Lett. 553, 200-204
82. Lassot, I., Latreille, D., Rousset, E., Sourisseau, M., Linares, L. K., Chable-Bessia, C., Coux, O., Benkirane, M., and Kiernan, R. E. (2007) The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol. Cell 25, 369-383